IGF-1R plays a key role in the development of aggressive BC through Ras/Raf/MAPK kinase 1/2/extracellular signal-regulated kinase 1/2 and PI3K/AKT/mammalian target of rapamycin (mTOR) signaling. Here, AKT1 is linked to breast cancer.